Epoetin alfa biosimilar (Amega Bitoech)

阿法依伯汀生物类似药 (Amega Bitoech)

Report date: 2022/01/14 13:23:58

Base Information

Drug NameEpoetin alfa biosimilar (Amega Bitoech)

Drug Alias Name阿法依伯汀生物仿制药 (Amega Bitoech)Erythropoietin follow-on biologic (Amega Bitoech)Recombinant erythropoietin (Amega Bitoech)Eritropoyetina alfa recombinante humana (Amega Bitoech)

ClassificationBiologics > BiosimilarBiologics > Protein drugs > Recombinant protein > Recombinant cytokines

Mechanisms of ActionErythropoiesis stimulantsErythropoietin receptor agonists

TargetsErythropoietin receptor

Therapy Area/IndicationsAnemia

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusApproved

Highest Status in ChinaN/A

Originator CompaniesAmega Biotech

China Registration ClassN/A

Develop Information

Active CompaniesAmega Biotech

Inactive CompaniesN/A

Active IndicationsAnemia

Inactive IndicationsN/A

Other Information

ATC CodeB03XA01